About this trial
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Arm 1
All samples and data are de-identified and HIPAA compliant
Arm 2
Subject is of scientific interest to the Sponsor or treating physician
Disqualifiers
Arm 1
Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
Arm 2
Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent
Trial population
Arm 1 - Female or male patient samples submitted to Sequenom or LabCorp affiliate for routine clinical care testing that no longer need to be maintained for clinical purposes. Arm 2 - Female or male subjects of scientific interest who have provided written informed consent/assent.
Trial design
Cohort
Other
Treatments tested in this trial
Multiple interventions depending on diagnostic test being run.
DeviceRemnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.
Treatment groups
Trial outcomes
Primary outcomes
Remnant samples and data for research and development
Remnant samples and data for research and development
Sample and data collection from subjects of scientific interest
Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sequenom, Inc.
Lead sponsor
Laboratory Corporation of America
Collaborator